FIELD: medicine.
SUBSTANCE: invention refers to medicine. What is declared is an agent inducing the hematopoietic stem cell differentiation into thrombocytes, representing a recombinant human cyclophilin A (rhCfA).
EFFECT: invention provides the extended range of products for specified application.
2 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PRECURSOR CELL (CD34+) MEASUREMENT IN BLOOD-FORMING TISSUE | 2012 |
|
RU2513511C1 |
| CYCLOPHILIN A AS GRANULOCYTOPOIESIS STIMULANT, RADIOPROTECTOR AND IMMUNE STIMULANT | 2008 |
|
RU2370277C1 |
| STRAIN Escherichia coli BL21(DE3)Gold/pETCYPopti - PRODUCER OF HUMAN RECOMBINANT CYCLOPHILIN A | 2015 |
|
RU2603283C1 |
| STRAIN Escherichia coli BL21(DE3)Gold/pETmin-CypA PRODUCING HUMAN RECOMBINANT CYCLOPHILIN A | 2013 |
|
RU2557305C2 |
| METHOD OF EARLY MOLECULAR-BIOLOGICAL DIAGNOSIS OF MALIGNANT GROWTHS AND AMYOTROPHIC LATERAL SCLEROSIS | 2018 |
|
RU2706714C1 |
| ANTICANCER AGENT | 2014 |
|
RU2575572C1 |
| CYCLOPHILINE A-MEDICATION, WHICH HAS HEPARINE-LIKE ACTION | 2010 |
|
RU2422152C1 |
| BIOMEDICAL CELL PRODUCT, METHOD FOR ITS PRODUCTION AND APPLICATION | 2018 |
|
RU2741769C2 |
| METHOD FOR OBTAINING BIOMEDICAL CELL PRODUCT FOR TREATMENT OF ONCOLOGICAL, NEURODEGENERATIVE AND AUTOIMMUNE DISEASES | 2019 |
|
RU2774350C2 |
| PERSONALIZED METHOD OF BONE MARROW RESTITUTION FOR CONTROLLING PROGRESSION AND RECURRENCES OF VARIOUS CIVILIZATION DISEASES, PREVENTING AGING AND SUDDEN DEATH | 2023 |
|
RU2817892C1 |
